Hepatitis Monthly

Published by: Kowsar

Occult Hepatitis C Virus Infection in Patients With Autoimmune Hepatitis

Mohammad Saeid Rezaee Zavareh 1 , 2 , Seyed Moayed Alavian 2 , * , Hamidreza Karimisari 1 , Mostafa Shafiei 2 and Seyed Yasser Saiedi Hosseini 2
Authors Information
1 Students' Research Committee, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Middle East Liver Diseases Center (MELD), Tehran, IR Iran
Article information
  • Hepatitis Monthly: August 01, 2014, 14 (8); e16089
  • Published Online: August 10, 2014
  • Article Type: Brief Report
  • Received: November 10, 2013
  • Revised: December 27, 2013
  • Accepted: February 24, 2014
  • DOI: 10.5812/hepatmon.16089

To Cite: Rezaee Zavareh M S, Alavian S M, Karimisari H, Shafiei M, Saiedi Hosseini S Y. et al. Occult Hepatitis C Virus Infection in Patients With Autoimmune Hepatitis, Hepat Mon. 2014 ;14(8):e16089. doi: 10.5812/hepatmon.16089.

Abstract
Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Bokharaei-Salim F, Keyvani H, Monavari SH, Alavian SM, Madjd Z, Toosi MN, et al. Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease. J Med Virol. 2011; 83(6): 989-95[DOI][PubMed]
  • 2. Castillo I, Pardo M, Bartolome J, Ortiz-Movilla N, Rodriguez-Inigo E, de Lucas S, et al. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis. 2004; 189(1): 7-14[DOI][PubMed]
  • 3. Castillo I, Bartolome J, Quiroga JA, Barril G, Carreno V. Diagnosis of occult hepatitis C without the need for a liver biopsy. J Med Virol. 2010; 82(9): 1554-9[DOI][PubMed]
  • 4. Carreno Garcia V, Nebreda JB, Aguilar IC, Quiroga Estevez JA. [Occult hepatitis C virus infection]. Enferm Infecc Microbiol Clin. 2011; 29 Suppl 3: 14-9[DOI][PubMed]
  • 5. Carreno V, Bartolome J, Castillo I, Quiroga JA. New perspectives in occult hepatitis C virus infection. World J Gastroenterol. 2012; 18(23): 2887-94[DOI][PubMed]
  • 6. Jadali Z, Alavian SM. Autoimmune diseases co-existing with hepatitis C virus infection. Iran J Allergy Asthma Immunol. 2010; 9(4): 191-206[PubMed]
  • 7. Krawitt EL. Autoimmune hepatitis. N Engl J Med. 2006; 354(1): 54-66[DOI][PubMed]
  • 8. Gossard AA, Lindor KD. Autoimmune hepatitis: a review. J Gastroenterol. 2012; 47(5): 498-503[DOI][PubMed]
  • 9. Bai L, Feng ZR, Lu HY, Li WG, Yu M, Xu XY. Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China. Chin Med J (Engl). 2009; 122(1): 5-9[PubMed]
  • 10. Cassani F, Cataleta M, Valentini P, Muratori P, Giostra F, Francesconi R, et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology. 1997; 26(3): 561-6[DOI][PubMed]
  • 11. Pavic S, Simonovic J, Boricic I, Svirtlih N. [Autoantibodies characteristic for autoimmune hepatitis found in chronic hepatitis C]. Srp Arh Celok Lek. 2003; 131(11-12): 437-42[PubMed]
  • 12. Vispo E, Maida I, Moreno A, Barreiro P, Soriano V. Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C. J Antimicrob Chemother. 2008; 62(6): 1470-2[DOI][PubMed]
  • 13. Kammer AR, van der Burg SH, Grabscheid B, Hunziker IP, Kwappenberg KM, Reichen J, et al. Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition. J Exp Med. 1999; 190(2): 169-76[PubMed]
  • 14. Michitaka K, Durazzo M, Tillmann HL, Walker D, Philipp T, Manns MP. Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2. Gastroenterology. 1994; 106(6): 1603-10[PubMed]
  • 15. Heintges T, Niederau C. Differentiation between autoimmune hepatitis and hepatitis C virus related liver disease. Z Gastroenterol. 1993; 31(5): 285-8[PubMed]
  • 16. Conrad B. Potential mechanisms of interferon-alpha induced autoimmunity. Autoimmunity. 2003; 36(8): 519-23[PubMed]
  • 17. Oeda S, Mizuta T, Isoda H, Kuwashiro T, Oza N, Iwane S, et al. Efficacy of pegylated interferon plus ribavirin in combination with corticosteroid for two cases of combined hepatitis C and autoimmune hepatitis. Clin J Gastroenterol. 2012; 5(2): 141-5[DOI][PubMed]
  • 18. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999; 31(5): 929-38[PubMed]
  • 19. Shafiei M, Alavian SM. Autoimmune hepatitis in Iran: what we know, what we don't know and requirements for better management. Hepat Mon. 2012; 12(2): 73-6[DOI][PubMed]
  • 20. Georgiadou SP, Zachou K, Liaskos C, Gabeta S, Rigopoulou EI, Dalekos GN. Occult hepatitis B virus infection in patients with autoimmune liver diseases. Liver Int. 2009; 29(3): 434-42[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments